Wise R, Johnson J, O'Sullivan N, Andrews J M, Imbimbo B P
Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.
J Antimicrob Chemother. 1991 Dec;28(6):905-9. doi: 10.1093/jac/28.6.905.
The pharmacokinetics of rufloxacin after a single 400 mg oral dose were studied in eight volunteers, measuring plasma, inflammatory fluid and urine concentrations. Mean peak plasma concentrations of 4.4 mg/L were achieved at a mean time of 1.9 h after administration. The mean plasma elimination half-life was 28.2 h. Mean peak levels in inflammatory fluid reached 3.2 mg/L after 3.5 h, and 30.7% of the dose was eliminated in urine by 96 h. The apparent mean volume of distribution of rufloxacin, at steady state, was 109.5 L. The mean percentage penetration of rufloxacin into the inflammatory exudate, as measured by ratios of AUC0-50 h was 90%.
在8名志愿者中研究了单次口服400 mg芦氟沙星后的药代动力学,测定了血浆、炎性液和尿液浓度。给药后平均1.9小时达到平均血浆峰浓度4.4 mg/L。平均血浆消除半衰期为28.2小时。炎性液中的平均峰浓度在3.5小时后达到3.2 mg/L,到96小时时30.7%的剂量经尿液排出。芦氟沙星在稳态时的表观平均分布容积为109.5 L。通过AUC0-50 h比值测定,芦氟沙星进入炎性渗出液的平均渗透百分比为90%。